Search

everythinglearnresearchcommunity

for

Search:↓

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

Combining laser hair removal with topical eflornithine is recommended for better results in treating unwanted facial hair.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

Menopause affects hair and skin; more research needed for treatment.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

South Asian women with PCOS present with different symptoms compared to White women, influenced by ethnicity, obesity, and age.

Finasteride reduces alcohol withdrawal effects, especially in female mice.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

Cognitive behavioral strategies help women with PCOS make lifestyle changes to improve their health.

The normal human prostate does not significantly affect blood DHT levels.